MARKET

LMAT

LMAT

LeMaitre
NASDAQ

Real-time Quotes | Nasdaq Last Sale

50.78
-0.60
-1.17%
After Hours: 50.78 0 0.00% 16:01 03/03 EST
OPEN
51.91
PREV CLOSE
51.38
HIGH
52.55
LOW
50.26
VOLUME
210.18K
TURNOVER
--
52 WEEK HIGH
54.96
52 WEEK LOW
18.76
MARKET CAP
1.03B
P/E (TTM)
55.24
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Be Sure To Check Out LeMaitre Vascular, Inc. (NASDAQ:LMAT) Before It Goes Ex-Dividend
LeMaitre Vascular, Inc. ( NASDAQ:LMAT ) is about to trade ex-dividend in the next four days. You can purchase shares...
Simply Wall St. · 19h ago
Neurovascular Embolectomy Device Market Share, Size, Growth, 2021 Industry Trends, Global Business Prospects, Forthcoming Developments, Analysis, Research, Impact of COVID-19 on Business and Forecast to 2025
Mar 02, 2021 (The Expresswire) -- Global "Neurovascular Embolectomy Device Market" (2021) thoroughly scrutinizes the effects of a wide range of factors...
The Express Wire · 1d ago
Neurovascular Embolectomy Device Market Size, Share | Global Companies, Consumption, Drivers, Growth Status, Top Leading Countries, Trends, Forces Analysis, Revenue, Challenges and Global Forecast 2027
Mar 02, 2021 (The Expresswire) -- Global Neurovascular Embolectomy Device Market Research Report offers in-depth analysis on Market size, share, drivers,...
The Express Wire · 1d ago
Uptrend Call Working As Lemaitre Vascula Stock Rises 34.5% (LMAT)
Mar 01, 2021 (SmarTrend(R) Spotlight via COMTEX) -- SmarTrend identified an Uptrend for Lemaitre Vascula (NASDAQ:LMAT) on December 22nd, 2020 at $38.04. In...
marketwatch.com · 2d ago
DJ LeMaitre Vascular's CEO George LeMaitre on Q4 2020 Results -- Earnings Call Transcript >LMAT
Dow Jones · 3d ago
--Analyst Actions: Barrington Adjusts LeMaitre Vascular PT to $49 From $47, Maintains Outperform Rating
MT Newswires · 5d ago
LeMaitre Vascular Q4 EPS $0.34 Beats $0.29 Estimate, Sales $37.55M Beat $35.58M Estimate
LeMaitre Vascular (NASDAQ:LMAT) reported quarterly earnings of $0.34 per share which beat the analyst consensus estimate of $0.29 by 17.24 percent. This is a 47.83 percent increase over earnings of $0.23 per share from
Benzinga · 6d ago
LeMaitre Vascular hikes quarterly dividend by ~16%
LeMaitre Vascular (LMAT) declares $0.11/share quarterly dividend, 15.8% increase from prior dividend of $0.10.Forward yield 0.94%Payable March 25; for shareholders of record March 9; ex-div March 8.See LMAT Dividend Scorecard,
Seekingalpha · 6d ago
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of LMAT. Analyze the recent business situations of LeMaitre through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 6 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average LMAT stock price target is 54.00 with a high estimate of 65.00 and a low estimate of 48.00.
EPS
Institutional Holdings
Institutions: 247
Institutional Holdings: 19.15M
% Owned: 94.12%
Shares Outstanding: 20.34M
TypeInstitutionsShares
Increased
59
1.30M
New
47
152.18K
Decreased
46
908.00K
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
-2.96%
Healthcare Equipment & Supplies
-2.63%
Key Executives
President/Director
David Roberts
Chief Financial Officer/Director
Joseph Pellegrino
Senior Vice President/General Counsel
Laurie Churchill
Senior Vice President
Andrew Hodgkinson
Senior Vice President
Trent Kamke
Vice President - Operations
Stephane Maier
Vice President/Director of Sales
Giovannella Deiure
Vice President/Director of Sales
Chance Kriesel
Vice President/Director of Marketing
Kimberly Cieslak
Vice President
Roli Kumar-Choudhury
Vice President
Jonathan Ngau
Vice President
Jacob Petersen
Vice President
Xiang Zhang
Vice President - Research & Development
Ryan Connelly
Director of Sales
Helen Goulding
Other
James Russell
Independent Director
Lawrence Jasinski
Independent Director
John O'Connor
Independent Director
Bridget Ross
Independent Director
John Roush
  • Dividends
  • Splits
  • Insider Activity
Declaration Date
Dividend Per Share
Ex-Div Date
02/23/2021
Dividend USD 0.11
03/08/2021
10/20/2020
Dividend USD 0.095
11/18/2020
07/21/2020
Dividend USD 0.095
08/26/2020
04/28/2020
Dividend USD 0.095
05/19/2020
01/30/2020
Dividend USD 0.095
03/02/2020
10/21/2019
Dividend USD 0.085
11/19/2019
07/22/2019
Dividend USD 0.085
08/20/2019
04/29/2019
Dividend USD 0.085
05/21/2019
02/14/2019
Dividend USD 0.085
03/21/2019
10/04/2018
Dividend USD 0.07
11/19/2018
07/23/2018
Dividend USD 0.07
08/21/2018
04/23/2018
Dividend USD 0.07
05/21/2018
02/15/2018
Dividend USD 0.07
03/21/2018
10/24/2017
Dividend USD 0.055
11/21/2017
07/25/2017
Dividend USD 0.055
08/21/2017
04/24/2017
Dividend USD 0.055
05/22/2017
02/16/2017
Dividend USD 0.055
03/20/2017
10/24/2016
Dividend USD 0.045
11/17/2016
07/25/2016
Dividend USD 0.045
08/18/2016
04/25/2016
Dividend USD 0.045
05/23/2016
02/22/2016
Dividend USD 0.045
03/17/2016
10/22/2015
Dividend USD 0.04
11/18/2015
07/23/2015
Dividend USD 0.04
08/18/2015
04/23/2015
Dividend USD 0.04
05/20/2015
02/23/2015
Dividend USD 0.04
03/18/2015
10/23/2014
Dividend USD 0.035
11/18/2014
07/24/2014
Dividend USD 0.035
08/19/2014
04/24/2014
Dividend USD 0.035
05/20/2014
02/20/2014
Dividend USD 0.035
03/18/2014
10/23/2013
Dividend USD 0.03
11/18/2013
07/24/2013
Dividend USD 0.03
08/19/2013
04/24/2013
Dividend USD 0.03
05/20/2013
02/21/2013
Dividend USD 0.03
03/18/2013
10/30/2012
Dividend USD 0.025
11/16/2012
07/25/2012
Dividend USD 0.025
08/15/2012
04/25/2012
Dividend USD 0.025
05/16/2012
02/23/2012
Dividend USD 0.025
03/16/2012
10/25/2011
Dividend USD 0.02
11/21/2011
07/26/2011
Dividend USD 0.02
08/17/2011
04/26/2011
Dividend USD 0.02
05/18/2011
02/24/2011
Dividend USD 0.02
03/18/2011
About LMAT
LeMaitre Vascular, Inc. is a provider of medical devices for the treatment of peripheral vascular disease. The Company develops, manufactures and markets medical devices and implants used primarily in the field of vascular surgery. It is engaged in the design, marketing, sales and technical support of medical devices and implants for the treatment of peripheral vascular disease industry segment. The Company's product lines include valvulotomes, balloon catheters, carotid shunts, biologic vascular patches, radiopaque marking tape, anastomotic clips, remote endarterectomy devices, laparoscopic cholecystectomy devices, prosthetic vascular grafts, biologic vascular grafts and powered phlebectomy devices. Its portfolio of peripheral vascular devices consists of brand name products that are used in arteries and veins outside of the heart, including the Expandable LeMaitre Valvulotome, the Pruitt F3 Carotid Shunt, VascuTape Radiopaque Tape and the XenoSure biologic patch.

Webull offers kinds of LeMaitre Vascular Inc stock information, including NASDAQ:LMAT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LMAT stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading LMAT stock methods without spending real money on the virtual paper trading platform.